HCW Biologics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-1.5M | $-1.5M | $23.3K | — |
| Jun 2021 | $-990.4K | $-990.4K | $0 | — |
| Sep 2021 | $-5.1M | $-5.1M | $4.1K | — |
| Dec 2021 | $-3.4M | $-3.4M | $19.9K | — |
| Mar 2022 | $-1.6M | $-1.6M | $23.6K | $260.3K |
| Jun 2022 | $-2.7M | $-2.7M | $12.9K | $271.3K |
| Sep 2022 | $-2.3M | $-12.5M | $10.2M | $302.3K |
| Dec 2022 | $-3.8M | $-3.9M | $68.7K | $286.2K |
| Mar 2023 | $-3.6M | $-3.9M | $300.4K | $259.2K |
| Jun 2023 | $-9.4M | $-10.9M | $1.6M | $263.4K |
| Sep 2023 | $-5.6M | $-6.2M | $630.1K | $219.8K |
| Dec 2023 | $-3.9M | $-7.6M | $3.7M | $261.3K |
| Mar 2024 | $-3.6M | $-3.7M | $129.7K | $244.7K |
| Jun 2024 | $-4.9M | $-4.8M | $-18.6K | $239.8K |
| Sep 2024 | $-2.9M | $-3.0M | $37.1K | $232.4K |
| Dec 2024 | $-2.8M | $-2.9M | $113.4K | $292.1K |
| Mar 2025 | $-3.5M | $-3.5M | $0 | $275.6K |
| Jun 2025 | $-3.3M | $-3.3M | $0 | $278.3K |
| Sep 2025 | $-3.2M | $-3.2M | $0 | $205.5K |
| Dec 2025 | $-3.4M | $-3.4M | $0 | $9.2K |
| Mar 2026 | $-1.6M | $-1.6M | — | $10.0K |
| Jun 2026 | $-4.0M | $-4.0M | — | $1.2K |